McGill IBD logo
Donate

Dr. Waqqas Afif


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.

Collaboration with Dr. Greg Rosenfeld, University of British Columbia

Study Title: Pro-Active Fecal Calprotectin Monitoring to Improve Patient Outcomes in Ulcerative Colitis: A Prospective Randomized Control Trial (PROMOTE-UC)


Study Title: Pilot study to assess de-escalation of ustekinumab therapy in patients with Crohn’s disease


Study Title: Therapeutic drug monitoring guided early optimization of Adalimumab in Crohn’s disease. A randomized open-label study


Collaboration with Dr. Sasha Bernatsky, Research Institute of the McGill University Health Centre

Sponsor: Canadian Institutes of Health Research (CIHR)

Study Title: Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs


In collaboration with Dr. Alex Gregorieff, Centre for Translational Biology, RI-MUHC & Dr. Irah King, Centre for Translational Biology, RI-MUHC

Study Title: Targeting the gut microbiome to improve COVID-19 disease outcomes

Dr. Talat Bessisow


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.

Study Title: Correlation between serum drug level and endoscopic mucosal healing in patients with inflammatory bowel disease treated with Vedolizumab and Ustekinumab


Sponsor: Robarts Clinical Trials Inc

Study Title: Stopping Aminosalicylate Therapy in Inactive Crohn’s Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority


Study Title: Quantification and Effects of Ustekinumab on the tissues of the colon.


Sponsor : Centre Hospitalier Universitaire de Bordeaux, France

Study Title: Microbial factors and microbiota in acute severe ulcerative colitis: a multidimensional approach


In collaboration with Dr. Sanjay Murthy, MD, MSc, FRCPC, University of Ottawa, The Ottawa Hospital – General Campus

Study Title: A Randomized, Parallel-Group, Non-Inferiority Trial Comparing Random AND Targeted Biopsies to Targeted Biopsies Alone for Neoplasia Detecon during Screening Colonoscopy in Adult Persons with Colonic Inflammatory Bowel Diseases: A Pilot Study (IBD-Dysplasia)

Dr. Alain Bitton


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.

Sponsor: Dr. Paul Moayyedi, McMaster University
Funding: Canadian Institutes of Health Research (CIHR)

Study Title: Inflammation, Microbiome, and Alimentation: Gastro-Intestinal and Neuropsychiatric Effects: the IMAGINE-SPOR chronic disease network


Study title: Identifying genes responsible for inflammatory bowel disease


Study Title: Mechanisms of microbiota in mucosal inflammation across the biologic demarcation of Ulcerative Colitis


Study Title: Mechanisms of intestinal inflammation following ileal resection for Crohn’s Disease


Sponsor: Dr. John D. Rioux, Montreal Heart Institute
Funding:  Génome Canada (Rioux), National Institutes of Health (Rioux) and Pfizer Canada Inc. (Rioux)
Study Title: iGenoMed – CHUM: Identification of biomarkers of response to molecularly-targeted therapies in inflammatory bowel diseases

Dr. Alain Bitton & Dr. Terry Sigman


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email: miirecherche.ibdresearch@muhc.mcgill.ca.

Sponsor: Dr. Kenneth Croitoru, Mount Sinai Hospital, Toronto ON with funding from Crohn’s and Colitis Canada

Study Title: A Multidisciplinary Human Study on the Genetic, Environmental and Microbial Interactions that Cause IBD (GEM Project)

Dr. Peter Lakatos


If you are interested in learning more about any of the clinical and research studies below or would like to volunteer as a research subject, please email Rita Kohen: rita.kohen@muhc.mcgill.ca

Study Title: Quality of Care Assessment of the MUHC IBD Center: Retrospective and Prospective Assessment of Quality or Care and Outcome Parameters before and after Installation of the IBD Center


Study Title: Patient-reported outcomes (PROs) vs objective measures of disease activity in ulcerative colitis: A prospective single-center cross-sectional study at the MUHC IBD Center


Study Title: Applying an objective serial patient monitoring algorithm in IBD patients newly treated with adalimumab in five hospital-based IBD centers in the province of Quebec: prospective and retrospective assessment of outcomes before and after inauguration of the home fecal calprotectin test (IBDoc)


Sponsor: McGill IBD Research Group

Study Title: Mechanistic Studies on Fibrogenesis in Crohn Disease

Your donations help deliver specialized and quality care to people with inflammatory bowel disease (IBD) in Quebec.

Your generosity benefits the IBD clinics at the Montreal General Hospital, the Montreal Children's Hospital and the Jewish General Hospital.

Donate